Solid Biosciences advances gene therapies for muscular and cardiac diseases, gaining FDA clearance for SGT-212 and targeting ...

Solid Biosciences (SLDB) stock was launched by Truist with a Buy rating based on positive catalysts and attractive valuation.

A live webcast of the presentation will be available on the Events page of the Investors section of the Company website or by clicking here. A webcast replay will be archived for 30 days on the Events ...

The new name draws from the company’s nearly two decades of work in ryanodine receptor (RyR) biology, which it has used to ...

Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for ...

Barclays PLC increased its stake in Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) by 412.1% in the 3rd quarter, ...

Figure 4. Holter tracings showing pleiomorphic and polymorphic ventricular tachycardia preceding the occurrence of ventricular fibrillation in a patient with catecholaminergic polymorphic ventricular ...

VT indicates ventricular tachycardia; VF, ventricular fibrillation ... as well as those delivered for ventricular tachyarrhythmias (monomorphic or polymorphic) that would have spontaneously terminated ...

Eleven studies describing sinoatrial (SA) nodal, atrioventricular (AV) nodal or infra-Hisian conduction parameters in the setting of cocaine use were found. Fourteen studies and two case series ...

Abstract and Introduction Drugs Used for Ventricular Rate Control Drugs Used to Restore and Maintain Sinus Rhythm Conclusions References Although a large study [58] of over 1500 patients has ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...